Public, NASDAQ:OMRI
NASDAQ Global Market
XplosiveStocks.com: Johnson & Johnson (NYSE: JNJ) Hot Stock on the Move!
Date: Mon, 01 Dec 2008 09:48:54 GMT
Tags:
XplosiveStocks.com: Johnson & Johnson (NYSE: JNJ) Hot Stock on the Move!
Trading Markets (press release) - 11 hours ago
Trading Markets (press release) - 11 hours ago
Dec 01, 2008 (M2 PRESSWIRE via COMTEX) -- OMRI | Quote | Chart | News | PowerRating -- XplosiveStocks.com tracks HOT stocks that are on the move! For FREE Stock Alerts visit the following link ...
J&J to Purchase Biotechnology Firm Omrix
Date: Wed, 26 Nov 2008 20:12:28 GMT
Tags:
J&J to Purchase Biotechnology Firm Omrix
Wall Street Journal Blogs - Nov 26, 2008
Wall Street Journal Blogs - Nov 26, 2008
By SHIRLEY S. WANG Johnson & Johnson said it will acquire biotechnology company Omrix Biopharmaceuticals Inc. for $438 million in an effort to expand its surgical-care business. Omrix, which has ...
Israeli VCs missed out on Omrix
Date: Wed, 26 Nov 2008 17:39:54 GMT
Tags:
Israeli VCs missed out on Omrix
Globes - Nov 26, 2008
Globes - Nov 26, 2008
11 years ago, Omrix Biopharmaceuticals Ltd. (Nasdaq:OMRI) founder and CEO Robert Taub said that nothing came of all the approaches he made to venture capital funds. He predicted then that the ...
Johnson & Johnson acquires Israel’s Omrix Biopharmaceuticals for $438 million
Date: Wed, 26 Nov 2008 01:01:35 GMT
Tags:
Johnson & Johnson acquires Israel’s Omrix Biopharmaceuticals for $438 million
TopNews - Nov 26, 2008
J&J Buys Omrix On The Cheap - Forbes
RTT News - Trading Markets (press release) - CanadianBusiness.com
TopNews - Nov 26, 2008
Johnson & Johnson (JNJ), US based pharmaceutical and FMCG major, has signed a deal to acquire Israel's Omrix Biopharmaceuticals (OMRI) for about $438 million in cash. Under the terms of the ...
Johnson & Johnson acquires Omrix Biopharmaceuticals - GlobesJ&J Buys Omrix On The Cheap - Forbes
RTT News - Trading Markets (press release) - CanadianBusiness.com
Omrix Biopharmaceuticals downgraded to "neutral"
Date: Tue, 25 Nov 2008 16:55:32 GMT
Tags:
Omrix Biopharmaceuticals downgraded to "neutral"
newratings.com - Nov 25, 2008
newratings.com - Nov 25, 2008
NEW YORK, November 25 (newratings.com) - Analyst Debjit Chattopadhyay of Boenning & Scattergood downgrades Omrix Biopharmaceuticals Inc (OMRI) to "neutral." In a research note published this ...
J&J to buy breast implant maker Mentor for $1.07B (AP)
Date: Mon, 1 Dec 2008 20:53:37 Etc/GMT
Tags:
In a move to become a major player in cosmetic and reconstructive surgery, health care products company Johnson & Johnson said Monday it will buy cosmetic-product and breast-implant maker Mentor Corp. for $1.07 billion.
J&J Finds A New Mentor (at Forbes.com)
Date: Mon, 1 Dec 2008 19:40:00 Etc/GMT
Tags:
[$$] J&J to Buy Implant Maker Mentor for $1.07 Billion (at The Wall Street Journal Online)
Date: Mon, 1 Dec 2008 19:11:54 Etc/GMT
Tags:
Johnson & Johnson Firms Things Up (at Motley Fool)
Date: Mon, 1 Dec 2008 18:34:08 Etc/GMT
Tags:
J&J to buy breast implant firm Mentor for $1.1 billion (Reuters)
Date: Mon, 1 Dec 2008 17:16:55 Etc/GMT
Tags:
Johnson & Johnson will buy breast implant maker Mentor Corp for $1.07 billion as the diversified healthcare giant pushes into the market for cosmetic medical procedures.